-
letlifehappen posted a blog post
By: Jessica Hergert From: onclive.com Nearly 1 year following the first checkpoint inhibitor approval in advanced triple-negative breast cancer, additional immunotherapeutic agents are poised to enter the field, according to Rita Nanda, MD. “Historically, breast cancer was not believed to be an immunogenically active tumor [type],” said Nanda. “We have seen some emerging—likely practice-changing—data that may lead to approvals of ...
The post Immunotherapy Continues to Show Promise in TNBC appeared first on Let Life Happen.10 months ago
Get Full Access Today It’s EASY and FREE!
Things you can do
More Questions
Find us on Facebook
Please help us spread the word about WhatNext so more people can find more relevant matches, gain more insight and feel a little less alone.